Session VII: Chronic Lymphocytic Leukemia 

Session Chairs: Alessandra Ferrajoli, MD and Kerry A. Rogers, MD       

Bringing Order to the Alphabet Soup (IV, BO, IVO, AV, AVO ZVO etc.) | Mary Ann Anderson, MBBS, FRACP, FRCPA, PhD | The University of Melbourne, Victoria, Australia

How Do We Define Refactory CLL | Paolo Ghia, MD, PhD | Università Vita-Salute San Raffaele Milano, Italy

Debate: Relapse After FD: Repeat Ven-Based - Pro | Catherine C. Coombs, MD | UCI Health, Orange, California, USA

Debate: Relapse After FD: Change to BTKi - Con | John N. Allan, MD | Weill Cornell Medicine, New York, New York, USA

Immunotherapy (CART, Bispecifics, etc.) in CLL | Jordan Gauthier, MD, MSc | Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Update on Richters | Mahesh Swaminathan, MD | MD Anderson Cancer Center, Houston, Texas, USA

Oral Abstract | TBD | Speaker | Affiliation